Ecofibre Ltd - Asset Resilience Ratio
Ecofibre Ltd (EOF) has an Asset Resilience Ratio of 6.67% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Ecofibre Ltd (EOF) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Ecofibre Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see EOF current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down Ecofibre Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read debt load of Ecofibre Ltd for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$3.87 Million | 6.67% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$3.87 Million | 6.67% |
Asset Resilience Insights
- Limited Liquidity: Ecofibre Ltd maintains only 6.67% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Ecofibre Ltd Industry Peers by Asset Resilience Ratio
Compare Ecofibre Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Piramal Pharma Limited
NSE:PPLPHARMA |
Drug Manufacturers - Specialty & Generic | 0.73% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Zhejiang Medicine Co Ltd
SHG:600216 |
Drug Manufacturers - Specialty & Generic | 1.85% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
Annual Asset Resilience Ratio for Ecofibre Ltd (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Ecofibre Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-06-30 | 0.28% | AU$200.00K ≈ $141.51K |
AU$71.25 Million ≈ $50.41 Million |
-0.01pp |
| 2023-06-30 | 0.29% | AU$347.00K ≈ $245.52K |
AU$118.73 Million ≈ $84.01 Million |
-4.69pp |
| 2022-06-30 | 4.99% | AU$7.46 Million ≈ $5.28 Million |
AU$149.55 Million ≈ $105.82 Million |
+1.97pp |
| 2021-06-30 | 3.02% | AU$4.28 Million ≈ $3.03 Million |
AU$141.75 Million ≈ $100.29 Million |
-10.29pp |
| 2020-06-30 | 13.31% | AU$11.22 Million ≈ $7.94 Million |
AU$84.30 Million ≈ $59.64 Million |
-35.74pp |
| 2019-06-30 | 49.05% | AU$23.43 Million ≈ $16.58 Million |
AU$47.77 Million ≈ $33.80 Million |
+24.59pp |
| 2018-06-30 | 24.46% | AU$2.76 Million ≈ $1.95 Million |
AU$11.27 Million ≈ $7.97 Million |
-15.83pp |
| 2017-06-30 | 40.29% | AU$2.45 Million ≈ $1.73 Million |
AU$6.08 Million ≈ $4.30 Million |
-- |
About Ecofibre Ltd
Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer te… Read more